Clinical Trial Update: Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating the use of levetiracetam (Keppra) for bipolar disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED